Aliv Suspension

Adult dose

Usually administered at a dose of 1 pouch orally three times a day after meals for adults.

This drug contains the artificial sweetener aspartame, which is broken down into phenylalanine in the body. Therefore, it should not be used by patients with phenylketonuria, a genetic disorder that requires restriction of phenylalanine intake. In addition, it should not be administered to patients with congenital maple syrup urine disease due to the risk of seizures or respiratory distress. When taking this medication, digestive symptoms such as constipation, diarrhea, abdominal distension, discomfort, and nausea may occur, and if these symptoms arise, the dosage should be reduced or temporarily discontinued. It may affect renal function, leading to an increase in BUN levels in blood tests, and there is also a risk of elevated serum ammonia levels due to metabolic disturbances, so dosage adjustments should be made if abnormal symptoms appear. Regarding liver function, AST, ALT, and bilirubin levels may rise, and side effects such as skin rash or itching, malaise, edema, and facial flushing have been reported. This medication is used in specific liver cirrhosis patients with low serum albumin levels and ascites or edema, where dietary guidance should be considered if adequate dietary intake is not possible. It should not be administered to patients with severe hepatic encephalopathy or markedly elevated total bilirubin levels where liver function is significantly impaired, as its effectiveness is not expected in such cases. As this drug contains only branched-chain amino acids, it cannot provide all essential amino acids, so patients should ensure sufficient protein and caloric intake from meals in accordance with their condition, and attention should be paid to potential nutritional deterioration with prolonged use. If serum BUN and ammonia levels rise, there is a risk of overdose, so caution is necessary, and if hypoalbuminemia does not improve after two months of use, alternative treatments should be considered. Elderly patients may be at greater risk of metabolic disturbances due to decreased physical function, thus caution is warranted during administration. Pregnant or breastfeeding women should only use this medication if the benefits of treatment outweigh the risks, as its safety has not been sufficiently established. Safety for children has not been proven, and experience with usage is limited, so caution is advised. This medication should be stored out of reach of children, and transferring it to another container is not advisable for quality maintenance and accident prevention. The aspartame content should be regulated to be below the WHO recommended levels, with a maximum daily dose of 2.4g for a 60kg adult.

Serious side effects

Edema (in the face, lower limbs, etc.) may correspond to severe swelling and should be monitored; however, there are no specific symptoms classified as definitively severe in the document.

Mild side effects

• Constipation
• diarrhea
• abdominal bloating
• abdominal discomfort
• nausea
• thirst
• burping
• abdominal pain
• vomiting
• loss of appetite

This medication is sensitive to light and should be stored in a light-resistant container. Additionally, it is important to store it at temperatures between 1 and 30 degrees Celsius to maintain the drug's effectiveness.

Appearance

A viscous suspension with a fruity flavor, white to yellowish, contained in aluminum foil pouches.

Package unit

20 pouches (20g/pouch x 20)